In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Once you understand what is, you'll spot Bayesian reasoning in science, medicine - and many aspects of daily life. Written and narrated by Sir David Spiegelhalter, Emeritus Professor of Statistics at ...

Pantelis Samartsidis, Claudia R. Eickhoff, Simon B. Eickhoff, Tor D. Wager, Lisa Feldman Barrett, Shir Atzil, Timothy D. Johnson, Thomas E. Nichols Journal of the ...